In this paper, stabilization of the structural system against earthquake is presented. Because the conventional PD controller is popular and simple in design, our controller is based on PD controller. The main problem of such a controller is its inability to produce desired response and instability against variations in the properties of the structural system. To obviate this issue, the neu...

The catalytic acvtivity of dimeric and monomeric ortho-palladated complexes [Pd{C6H2(CH2NH2-(OMe)2,3,4}(µ-Cl)]2)2) and [Pd{C6H2(CH2NH2-(OMe)2,3,4}Cl(PPh3)](3), was investigated in Heck cross-coupling reaction. These complexes are more active and efficient catalysts for Heck cross-coupling reaction. The palladium complexes 2 and 3 is employed in the Heck cross-coupling reaction between styrene a...

Thin films of SnO2 nanowires were successfully prepared by using chemical vapor deposition (CVD) process on quartz substrates. Afterwards, a thin  layer of palladium (Pd) as a catalyst was coated on top of nanowires. For the deposition of Pd, a simple and low cost technique of spray pyrolysis was employed, which caused an intensive enhancement on the sensing response of fabricated sensors...

background: free radical formation and oxidative stress might play an important role in the pathogenesis of parkinson's disease (pd). in vitro data indicate that neuromelanin (nm) pigment is formed the excess cytosolic catecholamine that is not accumulated into synaptic vesicles via the vesicular monoamine transporter 2 (vmat2). we designed this study to investigate the neuroprotective eff...

the aim of this study was to degrade furfural by a new nanotube system. to degrade some organic pollutants as well as to reduce the amount of furfural which is a well-known pollutant in oil industry, the photocatalytic process along with ultraviolet (uv) irradiation may be employed. in this study, the uv/tio2/pd system in which the nanoparticles of palladium doped into the titanium dioxide was ...

ABSTRACT Background and Objective: Parkinson's disease (PD) is an age-related neurodegenerative disorder with massive loss of dopaminergic neurons in the substantia nigra pars compacta. L-Dihydroxyphenylalanine (L-DOPA) substitution is still the gold standard therapy for PD. However, there has been little information available on neuroprotective and regenerative therapies for PD. Due to the neu...

Introduction: Parkinson’s disease (PD) is the second most neurodegenerative disorder which is characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Clinical symptoms do not appear until approximately 70% of dopaminergic neurons and 80% of the striatal dopaminergic terminals have been lost. Thus, detecting nonclinical factors such as detecting b...